Singular Genomics Systems Inc Forecast, price target & analysts
Singular Genomics Systems Inc Target price 2024 - Analyst rating & recommendation
Singular Genomics Systems Inc Classifications & Recommendation:
Singular Genomics Systems Inc Price Target
| Target Price | $6.50 |
| Price | $19.64 |
| Deviation |
66.90%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Singular Genomics Systems Inc price target 2025.
The average Singular Genomics Systems Inc target price is $6.50.
This is
66.90%
register free of charge
|
|
| A rating was issued by 3 analysts: 1 Analysts recommend Singular Genomics Systems Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Singular Genomics Systems Inc stock has an average upside potential 2025 of
66.90%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 2.91 | 3.35 |
| 277.92% | 15.26% | |
| EBITDA Margin | -3,219.24% | -2,681.84% |
| 71.66% | 16.69% | |
| Net Margin | -3,370.82% | -2,507.75% |
| 73.01% | 25.60% |
1 Analyst has issued a sales forecast Singular Genomics Systems Inc 2024 . The average Singular Genomics Systems Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Singular Genomics Systems Inc 2024 . The average Singular Genomics Systems Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Singular Genomics Systems Inc 2024 . The average Singular Genomics Systems Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -39.08 | -33.51 |
| 1.98% | 14.25% | |
| P/E | negative | |
| EV/Sales | negative |
1 Analysts have issued a Singular Genomics Systems Inc forecast for earnings per share. The average Singular Genomics Systems Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Singular Genomics Systems Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Singular Genomics Systems Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
